HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexander Baumann Selected Research

Squamous Cell Carcinoma of Head and Neck

2/2018The Aurora-Kinase A Phe31-Ile polymorphism as possible predictor of response to treatment in head and neck squamous cell carcinoma.
7/2014The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alexander Baumann Research Topics

Disease

2Neoplasms (Cancer)
04/2021 - 02/2018
2Squamous Cell Carcinoma of Head and Neck
02/2018 - 07/2014
1Camptocormia
01/2022
1Dysarthria (Spastic Dysarthria)
12/2018
1Esophageal Neoplasms (Esophageal Cancer)
02/2018

Drug/Important Bio-Agent (IBA)

2Aurora KinasesIBA
02/2018 - 07/2014
2Aurora Kinase AIBA
02/2018 - 07/2014
1diadenosine triphosphate (ApppA)IBA
01/2022
1Galectins (Galectin)IBA
04/2021
1SurvivinIBA
02/2018
1Cetuximab (Erbitux)FDA Link
07/2014

Therapy/Procedure

1Therapeutics
04/2021
1Aftercare (After-Treatment)
12/2018